- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
32 result(s) found for: Fatty Alcohol.
Displaying page 1 of 2.
EudraCT Number: 2006-003718-17 | Sponsor Protocol Number: 962 | Start Date*: 2007-05-21 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: RANDOMIZED DOUBLE-BLIND STUDY TO EVALUATE THE ADJUVANT EFFECT OF POLYNSATURED FATTY ACIDS OMEGA 3 IN THERAPY WITH DISULFIRAM IN DETOXIFIED LCOHOL-DEPENDENT SUBJECTS | |||||||||||||
Medical condition: DEPRESSION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003766-26 | Sponsor Protocol Number: 25-12-59 | Start Date*: 2009-10-12 | |||||||||||
Sponsor Name:Southampton University Hospitals NHS Trust | |||||||||||||
Full Title: The effects of purified n-3 fatty acids on serum biomarkers and cardiovascular risk markers in a randomized placebo controlled trial in patients with non alcoholic fatty liver disease | |||||||||||||
Medical condition: Non alcoholic fatty liver disease (NAFLD). This fatty liver disease may progress to a chronic condition that sometimes deteriorates further to cirrhosis and even liver carcinoma. To date there is n... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002456-90 | Sponsor Protocol Number: 14060802 | Start Date*: 2015-02-13 |
Sponsor Name:Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet | ||
Full Title: Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Alcohol Dependence: Effects of the FAAH inhibitor PF-04457845 on Extinction. A Randomized Controlled Trial. | ||
Medical condition: Current Posttraumatic Stress Disorder (PTSD) and Current Alcohol Dependence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-004141-24 | Sponsor Protocol Number: 228763 | Start Date*: 2018-01-26 | ||||||||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trus | ||||||||||||||||||
Full Title: A phase IV, open-label pilot study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised backgro... | ||||||||||||||||||
Medical condition: Non-alcoholic fatty liver disease in people living with well-controlled HIV-1 infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000963-15 | Sponsor Protocol Number: MATCH0.1 | Start Date*: 2016-01-19 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: MAcrophage Therapy for Liver Cirrhosis (MATCH) | |||||||||||||
Medical condition: Liver Cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005187-63 | Sponsor Protocol Number: FM101-CTP2-001 | Start Date*: 2021-04-14 | ||||||||||||||||
Sponsor Name:Future Medicine Co., Ltd. | ||||||||||||||||||
Full Title: A Randomized Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of FM101 in Adults with Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH) | ||||||||||||||||||
Medical condition: Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004373-50 | Sponsor Protocol Number: 369852 | Start Date*: 2021-04-08 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Effect of treatment with Semaglutide on cognitive function, neuroinflammation and hepatic nitrogen metabolism in patients with non-alcoholic steatohepatitis: A randomized placebo-controlled trial | |||||||||||||
Medical condition: Non-alcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002560-16 | Sponsor Protocol Number: 747-303 | Start Date*: 2015-12-10 | |||||||||||
Sponsor Name:Intercept Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) AT (Completed) SE (Completed) BE (Completed) DK (Completed) ES (Prematurely Ended) FI (Completed) PT (Prematurely Ended) HU (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004515-56 | Sponsor Protocol Number: hepatology_MT_2007-08 | Start Date*: 2008-04-28 |
Sponsor Name:Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG | ||
Full Title: Efficacy of ursodeoxycholic acid in the treatment of insulin resistance and vascular dysfunction in non-alcoholic fatty liver disease | ||
Medical condition: Non-alcoholic fatty liver disease (NAFLD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001983-31 | Sponsor Protocol Number: GT-031 | Start Date*: 2021-05-04 | ||||||||||||||||
Sponsor Name:Galectin Therapeutics Inc. | ||||||||||||||||||
Full Title: A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Es... | ||||||||||||||||||
Medical condition: Esophageal Varices in NASH Cirrhosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) GB (GB - no longer in EU/EEA) BE (Ongoing) PL (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001948-19 | Sponsor Protocol Number: IM101-603 | Start Date*: 2017-02-02 | |||||||||||||||||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||||||||||||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Adults with Active Primary Sjögrens Syndrome | |||||||||||||||||||||||||||||||||
Medical condition: Adults with moderately to severely Active Primary Sjögrens Syndrome | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: SE (Prematurely Ended) CZ (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002564-27 | Sponsor Protocol Number: STH16037 | Start Date*: 2013-01-31 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: Pilot open study of testosterone replacement in non-alcoholic steatohepatitis | ||
Medical condition: Non alcoholic fatty liver disease (NAFLD) in men with low serum testosterone levels | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000101-37 | Sponsor Protocol Number: IM128-035 | Start Date*: 2017-04-07 | |||||||||||||||||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||||||||||||||||||||||
Full Title: A Phase II, Randomized, Multi-Center, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of BMS-931699 (lulizumab) or BMS-986142 in Subjects with Moderate to Severe Primary ... | |||||||||||||||||||||||||||||||||
Medical condition: subjects with moderate to severe Sjögren's syndrome | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GR (Completed) IT (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-004970-16 | Sponsor Protocol Number: CS15-033 | Start Date*: 2017-05-30 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Imaging the functional and molecular impact of poly-unsaturated fatty acids on dopamine-dependent cognitive functions: a combined [11C]-(+)-PHNO PET/MRI study at different stages of cognitive impai... | |||||||||||||
Medical condition: This study will assess the effects of poly-unsaturated fatty acids on working memory (measured using an n-back test) in healthy volunteers, in subjects who are at high risk for developing a psychot... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003575-21 | Sponsor Protocol Number: | Start Date*: 2017-07-25 | |||||||||||
Sponsor Name:MRC Clinical Trials Unit at UCL | |||||||||||||
Full Title: A multicentre, 48 week randomised controlled factorial trial of adding maraviroc and/or metformin for hepatic steatosis in HIV-1-infected adults on combination antiretroviral therapy. | |||||||||||||
Medical condition: Hepatic steatosis in adults with chronic HIV-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002496-10 | Sponsor Protocol Number: GS-US-402-1852 | Start Date*: 2017-02-21 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000203-82 | Sponsor Protocol Number: SHP626-201 | Start Date*: 2016-11-09 | |||||||||||
Sponsor Name:Shire Human Genetic Therapies, Inc. | |||||||||||||
Full Title: A Phase 2 Double-Blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter... | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH), is a clinical condition occurring in individuals who do not drink excessive alcohol (>20 grams/day), yet have hepatic histology which is indistinguishable from ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005215-33 | Sponsor Protocol Number: CLJN452A2202 | Start Date*: 2016-06-17 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, 3- part, adaptive design, multicenter study to assess safety, tolerability and efficacy of tropifexor (LJN452) in patients with non-alcoholic steatoh... | |||||||||||||
Medical condition: Non-alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) IT (Completed) DE (Completed) NL (Completed) BE (Completed) AT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000975-18 | Sponsor Protocol Number: M13-397 | Start Date*: 2012-09-26 | |||||||||||
Sponsor Name:Abbott Laboratories GmbH | |||||||||||||
Full Title: Open-label, Randomized, Parallel-Group, Exploratory Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects with Nonalcoholic Steatohepatitis (NASH) and no... | |||||||||||||
Medical condition: Nonalcoholic Steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002833-31 | Sponsor Protocol Number: CLMB763X2201 | Start Date*: 2017-02-17 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, patient and investigator blinded, placebo-controlled, multicenter study to assess the safety, tolerability, pharmacokinetics and efficacy of LMB763 in patients with non-alcoholic stea... | |||||||||||||
Medical condition: non-alcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.